Charite - University Medicine Berlin: COVID-19 - What is Driving the Escalating Hyperinflammation
September 14, 2021
September 14, 2021
BERLIN, Germany, Sept. 14 (TNSJou) -- Charite - University Medicine Berlin issued the following news:
* * *
Study published in Nature suggests novel treatment option
* * *
The severity of COVID-19 is not determined solely by the SARS-CoV-2 virus itself; rather, it is the primary result of a dysregulated immune response. A team of researchers from Charite - Universitatsmedizin Berlin, the Max-Delbruck-Center for Molecular Medicine (MDC), Johanne . . .
* * *
Study published in Nature suggests novel treatment option
* * *
The severity of COVID-19 is not determined solely by the SARS-CoV-2 virus itself; rather, it is the primary result of a dysregulated immune response. A team of researchers from Charite - Universitatsmedizin Berlin, the Max-Delbruck-Center for Molecular Medicine (MDC), Johanne . . .